ALMS
ALUMIS INC.
NASDAQ · Healthcare · Biotechnology · US
$7.77
−0.64%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.73
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.11
- EPS estimate
- -$0.77
- Revenue actual
- $1.7M
- Revenue estimate
- $3.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12.9%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $27
- PT range
- $15 – $37
- Analysts
- 5
4 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.77 | -$1.11 | Miss -44.72% | $1.7M |
| May 14, 2026 | -$0.79 | -$0.74 | Beat 6.33% | $1.7M |
| Mar 19, 2026 | -$0.97 | -$0.95 | Beat 2.06% | $1.9M |
| Nov 13, 2025 | -$0.92 | -$1.06 | Miss -15.22% | $2.1M |
| Aug 13, 2025 | -$1.11 | -$1.17 | Miss -5.41% | $2.7M |
| May 14, 2025 | -$1.47 | -$1.82 | Miss -23.81% | $17.4M |
| Mar 19, 2025 | -$1.40 | -$0.23 | Beat 83.57% | $1.5M |
| Nov 13, 2024 | -$1.64 | -$1.73 | Miss -5.49% | — |
| Mar 30, 2024 | — | -$0.96 | — | — |
| Dec 30, 2023 | — | -$4.50 | — | — |
| Sep 30, 2023 | — | -$1.13 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026